| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| FEMY | FEMASYS INC | Chief Financial Officer | $21K | Nov 7, 2025 | ||
| CLRB | Cellectar Biosciences, Inc. | Chief Financial Officer | Jan 25, 2022 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|